Brimonidine/timolol

Feb 25, 2020

Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meeting

Apr 25, 2019

Allergan to Showcase Continued Eye Care Innovation with New Data at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Oct 01, 2018

Ocugen Initiates Phase 3 Clinical Trial of OCU310 for Dry Eye Disease

Jul 02, 2018

Global Ophthalmic Drugs Market Forecast 2018-2028 - Visiongain Report

May 02, 2018

Ocugen Presents Preclinical Efficacy Data of its Proprietary Nanoemulsion Technology at ARVO 2018

Mar 20, 2018

Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease

Dec 22, 2017

Bausch + Lomb Receives FDA Approval of LUMIFY(TM) - The Only Over-The-Counter Eye Drop With Low-Dose Brimonidine For The Treatment Of Eye Redness

Dec 22, 2017

Allergan Acknowledges Appeals Court Decision for COMBIGAN®

Sep 25, 2017

Ocugen Announces FDA Acceptance of Investigational New Drug Application for OCU310 (brimonidine/steroid combination therapy) and Initiates Proof of Concept Study for Treatment of Dry Eye Disease

Aug 30, 2017

Ophthalmic Drugs Market Forecast 2016-2026

Aug 09, 2017

Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease

Jun 26, 2017

Global Ophthalmic Drugs Market Forecast 2017-2027